Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,215 USD | -8,20 % |
|
-20,37 % | -62,61 % |
20/06 | VIRIOS THERAPEUTICS, INC. : Maxim Cambia su recomendación a compra | ZM |
20/05 | Principales caídas del mediodía | MT |
Resumen de negocios
Número de empleados: 4
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01/01/18 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 01/04/20 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 01/04/20 |
R. Gendreau
CTO | Chief Tech/Sci/R&D Officer | 68 | 28/02/12 |
Richard Burch
BRD | Director/Board Member | 67 | 01/01/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 21/12/20 |
Richard Whitley
BRD | Director/Board Member | 78 | 21/12/20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01/01/18 |
Abel de la Rosa
BRD | Director/Board Member | 61 | 21/12/20 |
Richard Burch
BRD | Director/Board Member | 67 | 01/01/14 |
David Keefer
BRD | Director/Board Member | 71 | 01/01/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 27 757 937 | 25 887 608 ( 93,26 %) | 0 | 93,26 % |
Información de la empresa
![Dirección Virios Therapeutics, Inc.(VIRI)](https://cdn.zonebourse.com/static/address/116702348.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-62,61 % | 5,97 M | |
+15,20 % | 121 mil M | |
+19,67 % | 113 mil M | |
+18,95 % | 26,02 mil M | |
-23,86 % | 19,39 mil M | |
-19,03 % | 15,91 mil M | |
-20,90 % | 15,09 mil M | |
-46,14 % | 15,06 mil M | |
+63,85 % | 14,93 mil M | |
+4,49 % | 13,85 mil M |
- Bolsa de valores
- Acciones
- Acción VIRI
- Empresa Virios Therapeutics, Inc.